Adsorption of surfactant protein D from human respiratory secretions by carbon nanotubes and polystyrene nanoparticles depends on nanomaterial surface modification and size

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1661, 2015, Pages

  Marchetti, Magda ^a,b   Shaffer, Milo S P ^c   Zambianchi, Martina ^a   Chen, Shu ^c   Superti, Fabiana ^b   Schwander, Stephan ^d   Gow, Andrew ^e   Zhang, Junfeng Jim ^f   Chung, Kian Fan ^a   Ryan, Mary P ^c   Porter, Alexandra E ^c   Tetley, Teresa D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

Carbon nanotubes; Lung; Polystyrene nanoparticles; Surfactant protein D adsorption

Indexed keywords

ADSORPTION; NANOTECHNOLOGY; PARTICLE SIZE; POLYMER; PROTEIN; SURFACTANT;

CARBON NANOTUBE; NANOPARTICLE; POLYSTYRENE DERIVATIVE; PROTEIN BINDING; SURFACTANT PROTEIN D;

ADSORPTION; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; HUMAN; PARTICLE SIZE; SURFACE PROPERTY;

ADSORPTION; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; NANOPARTICLES; NANOTUBES, CARBON; PARTICLE SIZE; POLYSTYRENES; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; SURFACE PROPERTIES;

EID: 84919740940     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0038     Document Type: Article

References (28)

1. Ikegami M, Na CL, Korfhagen TR, Whitsett JA. 2005 Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L552-L561. doi:10.1152/ajplung.00142.2004
2. Korfhagen TR et al. 1998 Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273, 28 438-28 443. doi.org/10.1074/jbc.273.43.28438
3. Tetley TD. 2007 Health effects of nanomaterials. Biochem. Soc. Trans. 35, 527-531. doi:10.1042/BST0350527
4. Bakshi MS, Zhao L, Smith R, Possmayer F, Petersen NO. 2008 Metal nanoparticle pollutants interferewith pulmonary surfactant function in vitro. Biophys. J. 94, 855-868. doi:10.1529/biophysj.107.106971
5. Schleh C et al. 2009 The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure. Respir. Res. 10, 90. doi:10.1186/1465-9921-10-90
6. Schleh C, Holzwarth U, Hirn S, Wenk A, Simonelli F, Schaffler M, Moller W, Gibson N, Kreyling WG. 2013 Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J. Aerosol Med. Pulm. Drug Deliv. 26, 24-30. doi:10.1089/jamp.2011.0951
7. Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr CM. 2011 Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur. J. Pharm. Biopharm. 77, 376-383. doi:10.1016/j.ejpb.2010.10.013
8. Kendall M, Ding P, Mackay RM, Deb R, McKenzie Z, Kendall K, Madsen J, Clark H. 2013 Surfactant protein D SP-D alters cellular uptake of particles and nanoparticles. Nanotoxicology 7, 963–973. doi.org/10.3109/17435390.2012.689880
9. Salvador-Morales C, Townsend P, Flahaut E, Venien-Bryan C, Vlandas A, Green MLH, Sim RB. 2007 Binding of pulmonary surfactant proteins to carbon nanotubes: potential for damage to lung immune defense mechanisms. Carbon 45, 607-617. doi:10. 1016/j.carbon.2006.10.011
10. Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, Gehr P, Krug HF, Rothen-Rutishauser B. 2012 Pulmonary surfactant coating of multi-walled carbon nanotubes MWCNTs influences their oxidative and pro-inflammatory potential in vitro. Part. Fibre Toxicol. 9, 17. doi:10.1186/ 1743-8977-9-17
11. Kapralov AA et al. 2012 Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6, 4147-4156. doi:10.1021/nn300626q
12. Ruge CA et al. 2012 The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. Plos One 7, 40775. doi:10.1371/journal.pone.0040775
13. Clark H, Reid K. 2003 The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch. Dis. Child. 88, 981-984. doi:10.1136/adc.88.11.981
14. Wang BM, Stern EJ, Schmidt RA, Pierson DJ. 1997 Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest 111, 460-466. doi:10.1378/chest.111.2.460
15. Doyle IR, Davidson KG, Barr HA, Nicholas TE, Payne K, Pfitzner J. 1998 Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am. J. Respir. Crit. Care Med. 157, 658-664. doi:10.1164/ajrccm.157.2.9701090
16. Crouch E, Persson A, Chang D. 1993 Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am. J. Pathol. 142, 241–248.
17. Chen S, Hu S et al. 2014 Aqueous cationic, anionic and non-ionic multi-walled carbon nanotubes, functionalised with minimal framework damage, for biomedical application. Biomaterials 35, 4729-4738. doi:10.1016/j.biomaterials.2014.02.002
18. Soerensen CM, Nielsen OL, Willis A, Heegaard PM, Holmskov U. 2005 Purification, characterization and immunolocalization of porcine surfactant protein D. Immunology 114, 72-82. doi:10.1111/j.1365-2567.2004.01999.x
19. Sager TM et al. 2014 Effect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse model. Nanotoxicology 8, 317–327. doi:10.3109/17435390.2013.779757
20. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008 Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 105, 14 265 -14 270. doi:10.1073/pnas.0805135105
21. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. 2006 A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 36, 189-217. doi:10.1080/10408440600570233
22. Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. 2011 A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int. J. Nanomed. 6, 2963–2979.
23. Hakansson K, Lim NK, Hoppe HJ, Reid KB. 1999 Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure 7, 255-264. doi:10.1016/S0969-21269980036-7
24. Ruenraroengsak P, Novak P, Berhanu D, Thorley AJ, Valsami-Jones E, Gorelik J, Korchev YE, Tetley TD. 2012 Respiratory epithelial cytotoxicity and membrane damage holes caused by amine-modified nanoparticles. Nanotoxicology 6, 94–108. doi:10.3109/17435390.2011.558643
25. Varela JA, Bexiga MG, Aberg C, Simpson JC, Dawson KA. 2012 Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. J. Nanobiotechnol. 10, 39. doi:10.1186/1477-3155-10-39
26. Mason RJ, Greene K, Voelker DR. 1998 Surfactant protein A and surfactant protein D in health and disease. Am. J. Physiol. 275, 1–13.
27. Kendall M, Brown L, Trought K. 2004 Molecular adsorption at particle surfaces: a PM toxicity mediation mechanism. Inhal. Toxicol. 16 Suppl 1, 99-105. doi:10.1080/08958370490443187
28. Snyder-Talkington BN, Qian Y, Castranova V, Guo NL. 2012 New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics. J. Toxicol. Environ. Health B Crit. Rev. 15, 468-492. doi:10.1080/10937404.2012.736856